Bannay Aurélie, Chaignot Christophe, Blotière Pierre-Olivier, Basson Mickaël, Weill Alain, Ricordeau Philippe, Alla François
*Faculté de médecine de Nancy, Université de Lorraine, Vandoeuvre les Nancy †CNAMTS, Paris, France.
Med Care. 2016 Feb;54(2):188-94. doi: 10.1097/MLR.0000000000000471.
The most used score to measure comorbidity is the Charlson index. Its application to a health care administrative database including International Classification of Diseases, 10th edition (ICD-10) codes, medical procedures, and medication required studying its properties on survival. Our objectives were to adapt the Charlson comorbidity index to the French National Health Insurance database to predict 1-year mortality of discharged patients and to compare discrimination and calibration of different versions of the Charlson index.
Our cohort included all adults discharged from a hospital stay in France in 2010 registered in the French National Health Insurance general scheme. The pathologies of the Charlson index were identified through ICD-10 codes of discharge diagnoses and long-term disease, specific medical procedures, and reimbursement of specific medications in the past 12 months before inclusion.
We included 6,602,641 subjects at the date of their first discharge from medical, surgical, or obstetrical department in 2010. One-year survival was 94.88%, decreasing from 98.41% for Charlson index of 0-71.64% for Charlson index of ≥5. With a discrimination of 0.91 and an appropriate calibration curve, we retained the crude Cox model including the age-adjusted Charlson index as a 4-level score.
Our study is the first to adapt the Charlson index to a large health care database including >6 million of inpatients. When mortality is the outcome, we recommended using the age-adjusted Charlson index as 4-level score to take into account comorbidities.
用于衡量合并症的最常用评分是查尔森指数。将其应用于包含国际疾病分类第10版(ICD - 10)编码、医疗程序和药物治疗信息的医疗保健管理数据库时,需要研究其在生存方面的特性。我们的目标是使查尔森合并症指数适用于法国国家健康保险数据库,以预测出院患者的1年死亡率,并比较不同版本查尔森指数的区分度和校准度。
我们的队列包括2010年在法国国家健康保险一般计划中登记的所有因住院而从医院出院的成年人。通过出院诊断的ICD - 10编码、长期疾病、特定医疗程序以及纳入前12个月内特定药物的报销情况来确定查尔森指数的疾病。
我们纳入了2010年首次从内科、外科或产科出院时的6,602,641名受试者。1年生存率为94.88%,查尔森指数为0时为98.41%,查尔森指数≥5时降至71.64%。由于区分度为0.91且校准曲线合适,我们保留了包含年龄调整后的查尔森指数作为4级评分的粗Cox模型。
我们的研究首次将查尔森指数应用于一个包含超过600万住院患者的大型医疗保健数据库。当以死亡率作为结局指标时,我们建议使用年龄调整后的查尔森指数作为4级评分来考虑合并症情况。